| Financial Year |
March 31 2023 |
| Monetary Funds |
3,541,027,753.31 |
| Held-for-trading Financial Assets |
103,451,873.75 |
| Notes Receivable |
329,198,783.93 |
| Accounts Receivable |
1,273,176,122.21 |
| Advances to Suppliers |
110,139,157.30 |
| Other Receivables |
111,012,680.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
26,558,092.53 |
| Inventories |
321,928,486.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
54,899,901.26 |
| Other Current Assets |
582,479,778.87 |
| Total Current Assets |
6,526,297,232.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,332,744.39 |
| Long-term Equity Investment |
2,124,051,993.21 |
| Investment Properties |
172,297,502.22 |
| Fixed Assetes |
7,315,767,793.55 |
| Under-construction Projects |
361,923,661.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,288,321,155.06 |
| R&D expenses |
-- |
| Goodwill |
1,290,620,498.81 |
| Long-Term Deferred and Prepaid Expenses |
93,984,946.26 |
| Deferred Income Tax Assets |
81,723,276.94 |
| Other Non-Current Assets |
22,734,911.84 |
| Sub-Total of Non-Current Assets |
14,332,282,119.28 |
| Total Assets |
20,858,579,351.58 |
| Short-Term Loans |
1,523,760,949.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
127,019,200.39 |
| Accounts Payable |
620,896,279.18 |
| Accounts Received In Advance |
1,532,354.68 |
| Employee Compensation Payable |
101,804,548.07 |
| Taxes Payable |
57,034,190.75 |
| Interest Payable |
-- |
| Dividend Payable |
18,248,916.04 |
| Other payables |
216,745,088.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
554,132,200.47 |
| Other Current Liabilities |
1,981,928,251.16 |
| Sub-Total of Current Liabilities |
5,448,604,641.96 |
| Long-term Loans |
3,788,817,170.96 |
| Bonds Payable |
1,798,256,610.03 |
| Long-Term Accounts Payable |
152,612,733.23 |
| Special Payable |
-- |
| Estimatied Liabilities |
58,498,593.50 |
| Deferred Income Tax Liabilities |
273,163,393.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,132,911,800.59 |
| Total Liabilities |
11,581,516,442.55 |
| Paid-In Capital(Or Share Stock) |
919,734,895.00 |
| Capital Surplus |
1,370,667,805.27 |
| Surplus Reserve |
152,420,826.52 |
| LESS:Treasury Stock |
26,708,456.60 |
| Undistributed Profits |
2,101,084,268.60 |
| Minority Stockholder's Interest |
2,759,262,542.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,517,800,366.93 |
| Owner's Equity（Stockholder's Equity） |
9,277,062,909.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,858,579,351.58 |
